Related references
Note: Only part of the references are listed.The Pharmacological Characteristics of Molecular-Based Inherited Salt-Losing Tubulopathies
Kandai Nozu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Macula Densa Sensing and Signaling Mechanisms of Renin Release
Janos Peti-Peterdi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Long-term follow-up of patients with Bartter syndrome type I and II
Elena Puricelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Rare Presentation of Cystinosis Mimicking Bartter's Syndrome: Reports of Two Patients and Review of the Literature
Aysun Caltik et al.
RENAL FAILURE (2010)
Amikacin-induced type 5 Bartter-like syndrome with severe hypocalcemia
A. Chrispal et al.
JOURNAL OF POSTGRADUATE MEDICINE (2009)
Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome
Karine Brochard et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Epilepsy, Ataxia, Sensorineural Deafness, Tubulopathy, and KCNJ10 Mutations.
Detlef Bockenhauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10
Ute I. Scholl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Successful Utilization of Aliskiren, a Direct Renin Inhibitor in Bartter Syndrome
David S. H. Bell
SOUTHERN MEDICAL JOURNAL (2009)
Hereditary Renal Tubular Disorders
Vimal Chadha et al.
SEMINARS IN NEPHROLOGY (2009)
Gitelman syndrome
Nine V. A. M. Knoers et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
An improved terminology and classification of Bartter-like syndromes
Hannsjoerg W. Seyberth
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance
Bernhard K. Kraemer et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism
Kandai Nozu et al.
PEDIATRIC NEPHROLOGY (2007)
Side-effects of long-term prostaglandin E1 treatment in neonates
Gyula Talosi et al.
PEDIATRICS INTERNATIONAL (2007)
A thiazide test for the diagnosis of renal tubular hypokalemic disorders
Giacomo Colussi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Transcriptional and functional analyses of SLC12A3 mutations:: New clues for the pathogenesis of Gitelman syndrome
Eva Riveira-Munoz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Patients with biallelic mutations in the chloride channel gene CLCNKB:: Long-term management and outcome
Alberto Bettinelli et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter
Carsten A. Pressler et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Increased systolic blood pressure with rofecoxib in congenital furosemide-like salt loss
Martin Koemhoff et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
A serum potassium level above 10 mmol/l in a patient predisposed to hypokalemia
David R. Phillips et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2006)
Hereditary polyuric disorders: New concepts and differential diagnosis
DG Bichet
SEMINARS IN NEPHROLOGY (2006)
Bartter's and Gitelman's syndromes: their relationship to the actions of loop and thiazide diuretics
RJ Unwin et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Bartter-like phenotype in Kearns-Sayre syndrome
F Emma et al.
PEDIATRIC NEPHROLOGY (2006)
Bartter syndromes and other salt-losing tubulopathies
Robert Kleta et al.
NEPHRON PHYSIOLOGY (2006)
Perinatal management of a preterm neonate affected by hyperprostaglandin E2 syndrome (HPS)
M Kömhoff et al.
ACTA PAEDIATRICA (2005)
Gitelman's not-so-benign syndrome
RT Pachulski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy:: A model for hyperprostaglandin E syndrome/antenatal Bartter syndrome
RM Nüsing et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child:: an unusual presentation of Dent's disease
N Besbas et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia
T Nijenhuis et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Salt handling in the distal nephron:: lessons learned from inherited human disorders
N Jeck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Salt wasting and deafness resulting from mutations in two chloride channels
KP Schlingmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter
SH Lin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Bartter syndrome: benefits and side effects of long-term treatment
MH Vaisbich et al.
PEDIATRIC NEPHROLOGY (2004)
Pharmacotyping of hypokalaemic salt-losing tubular disorders
SC Reinalter et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2004)
The role of cyclooxygenases and prostanoid receptorsin furosemide-like salt losing tubulopathy:: the hyperprostaglandin E syndrome
RM Nüsing et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2004)
Cardiac arrhythmias due to severe hypokalemia in a patient with classic Bartter disease
C Malafronte et al.
PEDIATRIC NEPHROLOGY (2004)
Temporal adaptation of tubuloglomerular feedback: Effects of COX-2
AH Deng et al.
KIDNEY INTERNATIONAL (2004)
Bartter syndrome
SC Hebert
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2003)
Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome
G Finer et al.
JOURNAL OF PEDIATRICS (2003)
A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes
I Zelikovic et al.
KIDNEY INTERNATIONAL (2003)
Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome
R Vargas-Poussou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Association between activating mutations of calcium-sensing receptor and Bartter's syndrome
S Watanabe et al.
LANCET (2002)
Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome
SC Reinalter et al.
KIDNEY INTERNATIONAL (2002)
Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family
KP Schlingmann et al.
NATURE GENETICS (2002)
Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies
M Peters et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure
R Birkenhäger et al.
NATURE GENETICS (2001)
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome:: Therapeutic use of the cyclooxygenase-2 inhibitor nimesulide
RM Nüsing et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies
SC Reinalter et al.
JOURNAL OF PEDIATRICS (2001)
Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness
N Jeck et al.
PEDIATRICS (2001)
Gitelman's syndrome revisited: An evaluation of symptoms and health-related quality of life
DN Cruz et al.
KIDNEY INTERNATIONAL (2001)
Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype
N Jeck et al.
PEDIATRIC RESEARCH (2000)
New treatment options for Bartter's syndrome
R Kleta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
